These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 38543755)
1. Ongoing Gaps in the Hepatitis C Care Cascade during the Direct-Acting Antiviral Era in a Large Retrospective Cohort in Canada: A Population-Based Study. Passos-Castilho AM; Murphy DG; Blouin K; Benedetti A; Panagiotoglou D; Bruneau J; Klein MB; Kwong JC; Sander B; Janjua NZ; Greenaway C Viruses; 2024 Mar; 16(3):. PubMed ID: 38543755 [TBL] [Abstract][Full Text] [Related]
2. The population level care cascade for hepatitis C in British Columbia, Canada as of 2018: Impact of direct acting antivirals. Bartlett SR; Yu A; Chapinal N; Rossi C; Butt Z; Wong S; Darvishian M; Gilbert M; Wong J; Binka M; Alvarez M; Tyndall M; Krajden M; Janjua NZ Liver Int; 2019 Dec; 39(12):2261-2272. PubMed ID: 31444846 [TBL] [Abstract][Full Text] [Related]
3. Population-level estimates of hepatitis C reinfection post scale-up of direct-acting antivirals among people who inject drugs. Yeung A; Palmateer NE; Dillon JF; McDonald SA; Smith S; Barclay S; Hayes PC; Gunson RN; Templeton K; Goldberg DJ; Hickman M; Hutchinson SJ J Hepatol; 2022 Mar; 76(3):549-557. PubMed ID: 34634387 [TBL] [Abstract][Full Text] [Related]
4. Disparities in direct acting antivirals uptake in HIV-hepatitis C co-infected populations in Canada. Saeed S; Strumpf EC; Moodie EE; Young J; Nitulescu R; Cox J; Wong A; Walmsely S; Cooper C; Vachon ML; Martel-Laferriere V; Hull M; Conway B; Klein MB; J Int AIDS Soc; 2017 Nov; 20(3):. PubMed ID: 29116684 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus reinfection after successful treatment with direct-acting antiviral therapy in a large population-based cohort. Rossi C; Butt ZA; Wong S; Buxton JA; Islam N; Yu A; Darvishian M; Gilbert M; Wong J; Chapinal N; Binka M; Alvarez M; Tyndall MW; Krajden M; Janjua NZ; J Hepatol; 2018 Nov; 69(5):1007-1014. PubMed ID: 30142429 [TBL] [Abstract][Full Text] [Related]
6. Engagement with the HCV care cascade among high-risk groups: A population-based study. Erman A; Everett K; Wong WWL; Forouzannia F; Greenaway C; Janjua N; Kwong JC; Sander B Hepatol Commun; 2023 Sep; 7(9):. PubMed ID: 37556245 [TBL] [Abstract][Full Text] [Related]
7. The Population Level Cascade of Care for Hepatitis C in British Columbia, Canada: The BC Hepatitis Testers Cohort (BC-HTC). Janjua NZ; Kuo M; Yu A; Alvarez M; Wong S; Cook D; Wong J; Grebely J; Butt ZA; Samji H; Ramji A; Tyndall M; Krajden M EBioMedicine; 2016 Oct; 12():189-195. PubMed ID: 27596150 [TBL] [Abstract][Full Text] [Related]
8. Gaps in hepatitis C virus prevention and care for HIV-hepatitis C virus co-infected people who inject drugs in Canada. Lanièce Delaunay C; Maheu-Giroux M; Marathe G; Saeed S; Martel-Laferrière V; Cooper CL; Walmsley S; Cox J; Wong A; Klein MB; Int J Drug Policy; 2022 May; 103():103627. PubMed ID: 35218989 [TBL] [Abstract][Full Text] [Related]
9. Characterizing the cascade of care for hepatitis C virus infection among Status First Nations peoples in Ontario: a retrospective cohort study. Mendlowitz AB; Bremner KE; Krahn M; Walker JD; Wong WWL; Sander B; Jones L; Isaranuwatchai W; Feld JJ CMAJ; 2023 Apr; 195(14):E499-E512. PubMed ID: 37040993 [TBL] [Abstract][Full Text] [Related]
10. Estimating the Consensus hepatitis C Cascade of Care among people who inject drugs in Australia: Pre and post availability of direct acting antiviral therapy. Iversen J; Dore GJ; Starr M; Catlett B; Cunningham P; Geddes L; Maher L Int J Drug Policy; 2020 Sep; 83():102837. PubMed ID: 32645585 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the hepatitis C cascade of care among people living with HIV in New South Wales, Australia: A data linkage study. Hosseini-Hooshyar S; Alavi M; Martinello M; Valerio H; Tillakeratne S; Matthews GV; Dore GJ J Viral Hepat; 2022 Apr; 29(4):271-279. PubMed ID: 35175671 [TBL] [Abstract][Full Text] [Related]
12. Recently acquired hepatitis C virus infection among people living with human immunodeficiency virus at a university hospital in Taiwan. Huang MH; Sun HY; Ho SY; Chang SY; Hsieh SM; Sheng WH; Chuang YC; Huang YS; Su LH; Liu WC; Su YC; Hung CC World J Gastroenterol; 2021 Oct; 27(37):6277-6289. PubMed ID: 34712032 [TBL] [Abstract][Full Text] [Related]
13. Impact of direct-acting antivirals for HCV on mortality in a large population-based cohort study. Janjua NZ; Wong S; Abdia Y; Jeong D; Buller-Taylor T; Adu PA; Samji H; Wilton J; Pearce M; Butt ZA; Yu A; Binka M; Bartlett S; Alvarez M; Krajden M J Hepatol; 2021 Nov; 75(5):1049-1057. PubMed ID: 34097994 [TBL] [Abstract][Full Text] [Related]
14. HCV Cascade of Care in HIV/HCV Co-Infected Individuals: Missed Opportunities for Micro-Elimination. Thomadakis C; Basoulis D; Tsachouridou O; Protopapas K; Paparizos V; Astriti M; Chini M; Chrysos G; Marangos M; Panagopoulos P; Kofteridis D; Sambatakou H; Mastrogianni E; Panatzis N; Pechlivanidou E; Psichοgiou M; Touloumi G; Viruses; 2024 May; 16(6):. PubMed ID: 38932178 [TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre- and post-universal access to direct-acting antiviral treatment in Australia: The LiveRLife study. Bajis S; Grebely J; Hajarizadeh B; Applegate T; Marshall AD; Ellen Harrod M; Byrne J; Bath N; Read P; Edwards M; Gorton C; Hayllar J; Cock V; Peterson S; Thomson C; Weltman M; Jefferies M; Wood W; Haber P; Ezard N; Martinello M; Maher L; Dore GJ; J Viral Hepat; 2020 Mar; 27(3):281-293. PubMed ID: 31698545 [TBL] [Abstract][Full Text] [Related]
16. Previous incarceration impacts access to hepatitis C virus (HCV) treatment among HIV-HCV co-infected patients in Canada. Kronfli N; Nitulescu R; Cox J; Moodie EE; Wong A; Cooper C; Gill J; Walmsley S; Martel-Laferrière V; Hull MW; Klein MB; J Int AIDS Soc; 2018 Nov; 21(11):e25197. PubMed ID: 30460791 [TBL] [Abstract][Full Text] [Related]
17. Women in the 2019 hepatitis C cascade of care: findings from the British Columbia Hepatitis Testers cohort study. Pearce ME; Bartlett SR; Yu A; Lamb J; Reitz C; Wong S; Alvarez M; Binka M; Velásquez Garcia H; Jeong D; Clementi E; Adu P; Samji H; Wong J; Buxton J; Yoshida E; Elwood C; Sauve L; Pick N; Krajden M; Janjua NZ BMC Womens Health; 2021 Sep; 21(1):330. PubMed ID: 34511082 [TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus care cascade in persons experiencing homelessness in the United States in the era of direct-acting antiviral agents: A scoping review. Del Rosario A; Eldredge JD; Doorley S; Mishra SI; Kesler D; Page K J Viral Hepat; 2021 Nov; 28(11):1506-1514. PubMed ID: 34314081 [TBL] [Abstract][Full Text] [Related]
19. Hepatitis C care cascade before and during the direct-acting antiviral eras in New South Wales, Australia: A population-based linkage study. Yousafzai MT; Alavi M; Valerio H; Hajarizadeh B; Grebely J; Dore GJ J Viral Hepat; 2023 Mar; 30(3):250-261. PubMed ID: 36537024 [TBL] [Abstract][Full Text] [Related]
20. Exploring hepatitis C virus testing and treatment engagement over time in Melbourne, Australia: a study protocol for a longitudinal cohort study (EC-Experience Cohort study). O'Keefe D; Gunn J; Ryan K; Djordjevic F; Kerr P; Gold J; Elsum I; Layton C; Chan K; Dietze P; Higgs P; Doyle J; Stoové MA; Hellard M; Pedrana AE BMJ Open; 2022 Jan; 12(1):e057618. PubMed ID: 34983773 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]